Microsoft's stock has surged over 25% since mid-last year. Read more to see why I downgrade MSFT from buy to sell.

Innergex strategically reduced its dividend and up-financed hydro assets. Read more to see why INGXF stock has substantial ...

YieldMax TSLA Option Income Strategy ETF has historically underperformed, but recent political developments involving Elon ...

Palantir’s multi-decade prowess in advanced mission-critical analytics is already making its AI genuinely valuable. Read why ...

Chances are high that the Bitcoin dominance has either already peaked for this cycle or will peak in November or December ...

Booz Allen Hamilton anticipates significant growth in its cybersecurity business. Read why I reiterate a Strong Buy rating ...

Microsoft's $13 billion partnership with OpenAI underscores its ambitious AI strategy. Click here to read why MSFT stock is a ...

David Abrams’ 13F portfolio value increased from $5.11B to $6.23B in Q3 2024, with the top three stakes comprising ~66%. The ...

I reiterate a 'Buy' rating for Zoetis with a one-year target price of $210 per share, driven by strong product performance ...

Global Medical REIT's Q3-2024 results show flat rental revenue and AFFO. Check out a few concerns with GMRE stock and why it ...

Target Resources cut its dividend in 2020 to repay debt faster, reflecting its aggressive growth strategy. See why TRGP stock ...

Maxim Power's transition to a new plant and market shift increase shareholder value. Click here to read why MXG:CA stock is a ...